The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamperschroer, C.
Right arrow Articles by Quinn, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamperschroer, C.
Right arrow Articles by Quinn, D. G.
The Journal of Immunology, 2002, 169: 340-349.
Copyright © 2002 by The American Association of Immunologists

The Role of Proinflammatory Cytokines in Wasting Disease During Lymphocytic Choriomeningitis Virus Infection1

Cris Kamperschroer and Daniel G. Quinn2

Department of Microbiology and Immunology, Loyola University Chicago Medical Center, Maywood, IL 60153

Infection with pathogens often leads to loss of body weight, but the cause of weight loss during infection is poorly understood. We used the infection of mice with lymphocytic choriomeningitis virus (LCMV) as a model to study how pathogens induce weight loss. If LCMV is introduced into the CNS of CTL-deficient mice, the immune response against the virus leads to a severe weight loss called wasting disease. We planned to determine what components of this antiviral immune response mediate wasting disease. By adoptive transfer, we show that CD4 T cells activated by LCMV infection are sufficient to cause wasting disease. We examined the role of cytokines in LCMV-induced wasting disease using mice lacking specific cytokines or cytokine receptors. Results of adoptive transfer experiments suggest that TNF-{alpha} is not involved in LCMV-induced wasting disease and show that IFN-{gamma} contributes to the disease. Consistent with a role for IFN-{gamma} in wasting, we find that IFN-{gamma} is necessary for LCMV-specific CD4 T cell responses in the CNS, most likely because it is required to induce MHC class II expression. Our data also indicate that IL-1 is required for LCMV-induced wasting and that IL-6 contributes to the wasting disease. Additionally, our results identify {alpha}-melanocyte-stimulating hormone as a potential mediator of the disease. Overall, this work defines the critical role of virus-primed CD4 T cells and of proinflammatory cytokines in the pathogenesis of wasting disease induced by LCMV infection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. A. Pedras-Vasconcelos, M. Puig, C. Sauder, C. Wolbert, M. Ovanesov, D. Goucher, and D. Verthelyi
Immunotherapy with CpG Oligonucleotides and Antibodies to TNF-{alpha} Rescues Neonatal Mice from Lethal Arenavirus-Induced Meningoencephalitis
J. Immunol., June 15, 2008; 180(12): 8231 - 8240.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Jupelli, M. N. Guentzel, P. A. Meier, G. Zhong, A. K. Murthy, and B. P. Arulanandam
Endogenous IFN-{gamma} Production Is Induced and Required for Protective Immunity against Pulmonary Chlamydial Infection in Neonatal Mice
J. Immunol., March 15, 2008; 180(6): 4148 - 4155.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
W. Masocha, M. E. Rottenberg, and K. Kristensson
Minocycline impedes african trypanosome invasion of the brain in a murine model.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1798 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kikuchi, M.-L. Santiago-Raber, H. Amano, E. Amano, L. Fossati-Jimack, T. Moll, B. L. Kotzin, and S. Izui
Contribution of NZB Autoimmunity 2 to Y-Linked Autoimmune Acceleration-Induced Monocytosis in Association with Murine Systemic Lupus.
J. Immunol., March 1, 2006; 176(5): 3240 - 3247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Fuller and A. J. Zajac
Ablation of CD8 and CD4 T Cell Responses by High Viral Loads
J. Immunol., January 1, 2003; 170(1): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. Hunziker, M. Recher, A. Ciurea, M. M.A. Martinic, B. Odermatt, H. Hengartner, and R. M. Zinkernagel
Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology
J. Exp. Med., October 21, 2002; 196(8): 1039 - 1046.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.